Public research preview
Gilbert Cisneros, Representative disclosure: BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)
Disclosed a buy transaction in BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 15 Dec 2025, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 32 days
Timeline
Transaction date
13 Nov 2025
Public disclosure
15 Dec 2025
Now
Tracked today
Filing delay: 32 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 7 Sept 2026
Stock path
BCRX from pre-transaction context through latest close.
Bought
13 Nov 2025 · 6.9 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Filed within 30 days.
- Not public yet
- Would not buy
- Observed transaction close
- 6.9
- Observed disclosure close
- 7.59
- Observed latest close
- 9.96
- Pre-disclosure move
- +10.0%
- Post-disclosure move
- +31.2%
- Market-adjusted move
- +17.1%
- 1w since disclosure
- +0.3%
- 1m since disclosure
- -10.7%
- 3m since disclosure
- +22.5%
- Pre-disclosure peak run-up
- +13.8%
- Retrace from peak
- -3.3%
Why Copy Window is Probably too late
Supporting factors
- Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $1,001 - $15,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 15 Dec 2025, 00:00
- Parser confidence
- 94%
- Instrument mapping
- 95%